In8Bio (INAB) Accumulated Depreciation (2020 - 2026)
In8Bio (INAB) reported Accumulated Depreciation of $3.44 million for Q1 2026, up 36.7% from $2.52 million a year earlier and up 7.7% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Accumulated Depreciation (2020 - 2026) Analysis & Trends
At the end of FY2025, In8Bio posted Accumulated Depreciation of $3.2 million, up 41.4% from FY2024.
- Accumulated Depreciation has increased for three consecutive years, with a five-year compound annual growth rate of 65.6% (FY2020 to FY2025).
- By year, Accumulated Depreciation came in at $2.26 million in FY2024 (+76.4%), $1.28 million in FY2023 (+299.7%), $321,000 in FY2022 (-7.2%) and $346,000 in FY2021 (+34.6%).
- The Q1 2026 figure ranks as the highest quarterly Accumulated Depreciation in data going back to Q4 2020.
- The high point for year-over-year Accumulated Depreciation in five years was Q4 2023 (growth of 299.7%); the low point was Q4 2022 (a decline of 7.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.44 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 807,000.00 |
| Mar 31, 2023 | 564,000.00 |
| Dec 31, 2022 | 321,000.00 |
| Sep 30, 2022 | 417,000.00 |
| Jun 30, 2022 | 384,000.00 |
| Mar 31, 2022 | 362,000.00 |
| Dec 31, 2021 | 346,000.00 |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 301,000.00 |
| Dec 31, 2020 | 257,000.00 |
API Access
In8Bio Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();